Buy IMIGRAN 6mg Injection 1s Online At Best Price In Pakistan

Dosage

Missed Dose

Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of a missed dose is very low.

Overdose

Since this medicine is administered in the hospital setting by a qualified healthcare professional, the likelihood of an overdose is very less. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.

Interactions

Fluvoxamine   (severe)

Ondansetron   (severe)

Sertraline   (severe)

Oxycodone   (moderate)

Almotriptan   (moderate)

Nefazodone   (moderate)

Naratriptan   (severe)

Tapentadol   (severe)

Prescribes

Migraine Headache

This medicine is used to relieve symptoms of a migraine headache (occur in one side of the head), It may occur with symptoms like sensitivity to light, sound, nausea, and vomiting, etc.

Cluster headache

This medicine is used to relieve symptoms of a cluster headache (severe painful headache).

Side Effects

Chest pain  

Drowsiness  

Dizziness  

Shortness of breath  

Feeling of warmth or heat  

Irregular heartbeat  

Itching  

Numbness  

Nausea and Vomiting  

Unusual tiredness and weakness  

Warnings

High cholesterol

Seizure disorder

Wolff-parkinson white syndrome

Use in children

Driving or operating machinery

Pregnancy

Breast-feeding

When Not To Use

Allergy

This medicine is not recommended for use in patients with a known allergy to IMIGRAN 6mg Injection 1s or any other inactive ingredients present in the formulation.

Cardiovascular Disease

This medicine is not recommended for use in patients with a known history of cardiovascular diseases due to the increased risk of worsening of the patient's condition.

Uncontrolled hypertension

This medicine is not recommended for use in patients with a history of uncontrolled hypertension due to the increased risk of very high blood pressure and hypertensive crisis.

Peripheral vascular diseases

This medicine is not recommended for use in patients with a known history of peripheral vascular diseases due to the increased risk of worsening of the patient's condition.

Severe liver disease

This medicine is not recommended for use in patients with severe liver disease due to the increased risk of worsening of the patient's condition.

Monoamine oxidase inhibitors (MAOI)

This medicine is not recommended for use in patients taking monoamine oxidase inhibitors (MAOI) due to the increased risk of a life-threatening condition called Serotonin Syndrome. A time gap of at least 14 days should be maintained between stopping therapy with MAOIs and starting therapy with this medicine.

Hemiplegic or Basilar Migraine

This medicine is not recommended for use in patients with hemiplegic or basilar migraine, due to the increased risk of worsening of the patient's condition.